Cascade-activatable nano-prodrug amplifies ROS-RNS signaling to target NQO1-associated redox vulnerability for melanoma therapy

Journal of Nanobiotechnology · Published 2026-08-03 · DOI 10.1186/s12951-026-04825-0

Free full text

Authors (12)

Honglin Tang, Chongzhi Wu, Wei Wang, Xi Cheng, Yong Dong, Zhiyuan Gao, Pengfei Chen, Xin Xie, Yong Huang, Lihe Sun, Bowen Li, Da Li

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Tang, H., Wu, C., Wang, W., et al. (2026). Cascade-activatable nano-prodrug amplifies ROS-RNS signaling to target NQO1-associated redox vulnerability for melanoma therapy. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-026-04825-0

Related articles